UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019740
Receipt number R000022795
Scientific Title A multicenter randomized controlled trial on early fluid resuscitation in extensively burned patients.
Date of disclosure of the study information 2015/11/16
Last modified on 2021/05/15 10:24:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter randomized controlled trial on early fluid resuscitation in extensively burned patients.

Acronym

Burn RCT on fluid resuscitation.

(FORECAST Burn)

Scientific Title

A multicenter randomized controlled trial on early fluid resuscitation in extensively burned patients.

Scientific Title:Acronym

Burn RCT on fluid resuscitation.

(FORECAST Burn)

Region

Japan


Condition

Condition

Burn

Classification by specialty

Emergency medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study was to verify the effectiveness to attenuate excessive fluid using a resuscitation fluid formula advocated by American Burn Association for Burn Injuries on early resuscitation in extensively burned patients.

Basic objectives2

Others

Basic objectives -Others

The respiratory dysfunction within 1 week after burn
(PaO2/FiO2 ratio)

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The respiratory dysfunction within 1 week after burn.
(PaO2/FiO2 ratio)

Key secondary outcomes

1. Renal dysfunction within 1 week after burn.
(serum creatinine and BUN)
2. Occurrence rate of abdominal compartment syndrome within 28 days after burn.
3. The 28-day and hospital mortality.
4. Fluid volume required within 48 hours after burn.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

Dose comparison

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Dose of Ringer lactate solution
(2mL*%TBSA*body weight divided by 2*8 hours is started/4mL*%TBSA*body weight
divided by 2*8 hours is started)

Interventions/Control_2

Initial resuscitation period
(2 days/2 days)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

21 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with burn surface area of 20-80%TBSA and age >21 years old.

Key exclusion criteria

Cardiopulmonary arrest
Chemical burn
Electric burn
Case with time interval beyond 4 hours after burn
Case received fluid resuscitation before the arrival
Comorbidity; heart disease, COPD, chronic renal failure, hepatic cirrhosis.
Case combined trauma.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Satoshi
Middle name
Last name GANDO

Organization

Hokkaido University Graduate School of Medicine

Division name

Acute and Critical Care Medicine

Zip code

060-8638

Address

N15W7, Kita-ku, Sapporo

TEL

+81-11-706-7377

Email

gando@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Shuta
Middle name
Last name Fukuda

Organization

Japanese Association for Acute Medicine

Division name

Office

Zip code

113-0033

Address

3-3-12, Hongo, Bunkyo-ku, Tokyo

TEL

+81-3-5840-9870

Homepage URL

https://c.umin.ac.jp/idc/index?proj_id=P00221&ctl=user

Email

editorial-jaam@umin.net


Sponsor or person

Institute

Japanese Association for Acute Medicine
Japanese Society for Burn Injuries

Institute

Department

Personal name



Funding Source

Organization

Japanese Association for Acute Medicine, Japan Society for the Promotion of the Science

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hokkaido University Graduate School of Medicine

Address

N15W7, Kita-ku, Sapporo

Tel

+81-3-5840-9870

Email

gando@med.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 11 Month 16 Day


Related information

URL releasing protocol

http://www.jaam.jp/html/jaamforecast/index.html

Publication of results

Published


Result

URL related to results and publications

https://www.sciencedirect.com/science/article/pii/S2468912221000092?via%3Dihub

Number of participants that the trial has enrolled

39

Results

There were no statistically significant differences between the 2 groups in the serum creatinine, and acute kidney injury based on the KDIGO guideline within 48 h after arrival at the hospital, survival rate on the 28th day, and discharge survival rate. The Modified Brooke formula group failed to achieve the target urine output corresponding to the infusion volume within 8 h after arrival, especially in more than 40% TBSA burn patients, but it did not become a clinical problem.

Results date posted

2021 Year 05 Month 15 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2021 Year 03 Month 26 Day

Baseline Characteristics

The inclusion criteria were as follows. More than 21 years old, a burn area of 20%- 80% TBSA, and freely agreed to the contents of the document after giving their informed consent. The exclusion criteria were cardiopulmonary arrest before or on arrival, more than 4 h lapsed from injury to hospitalization, transfer cases with initial resuscitation already started, chemical burn, electric shock burn, history of heart disease (e.g. old myocardial infarction or valvular heart disease), history of chronic respiratory disease (e.g. chronic obstructive pulmonary disease and pulmonary fibrosis), history of renal disorders (e.g. chronic renal failure), liver cirrhosis of Child-Pugh classification C and complicated with trauma with an Abbreviated Injury Scale(AIS) more than 3.

Participant flow

The study design was an exploratory, randomized, open-label, and controlled trial. This randomization was performed by the Pocock method based on the factors of burn surface area, inhalation injury, age, and gender at each facility. The registration of cases and randomization into two groups were performed by participating in registration facilities on the UMIN's website. One group was the conventional group treated using lactated Ringer's solution based on the Baxter formula, and the other was the intervention group treated using the fluid resuscitation method shown in the Modified Brooke formula.

Adverse events

Nothing

Outcome measures

The primary endpoint was a respiratory disorder P/F (PaO2/FiO2) ratio within 1 week after burn injury. The arterial blood sample was collected from an arterial line at the designated time point according to the time of arrival at the hospital, and data were acquired. Therefore, the data obtained by arterial blood sampling at that time show the result of a single data point and not the results of data acquired multiple times. Secondary endpoints were renal disorder (serum creatinine and blood urea nitrogen) within 48 h, the occurrence rate of abdominal compartment syndrome (ACS) within 28 days, survival rate on the 28th day, and volume of fluid resuscitation required for 2 days after hospitalization. We also examined each endpoint, including the urine output per body weight and hour, in the major burn patients with 20%-80% TBSA and with 40%-80% TBSA.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 11 Month 16 Day

Date of IRB

2015 Year 08 Month 10 Day

Anticipated trial start date

2016 Year 01 Month 01 Day

Last follow-up date

2019 Year 12 Month 31 Day

Date of closure to data entry

2019 Year 12 Month 31 Day

Date trial data considered complete

2019 Year 12 Month 31 Day

Date analysis concluded

2021 Year 03 Month 26 Day


Other

Other related information



Management information

Registered date

2015 Year 11 Month 10 Day

Last modified on

2021 Year 05 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022795


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name